Compounded Sterile Preparations Pharmacy

Dr. Hawkins is the Compounding Pharmacy Program Manager at the Lexington VA Health Care System (HCS) in Lexington, KY. She coordinates and oversees compounding activities, compliance, and quality assurance for the HCS’s main hospital and Community Living Center, as well as a variety of outpatient specialty clinics, including Urology, Ophthalmology, Infusion, Dermatology, and Chemotherapy. She represents her Veterans Integrated Services Network (VISN) on the National VA Compounded Drug workgroup. Dr. Hawkins is serving on the USP Healthcare Quality & Safety- Compounding Expert Committee for 2025 to 2030. She has speaking experience at national and state-level conferences and has experience as an item writer, ghost writer, and a pharmacy compliance and patient safety consultant. She received her Doctor of Pharmacy from Ohio Northern University, has a teaching certificate from the University of Kentucky’s College of Pharmacy, and completed a PGY1 residency at Baptist Health Lexington. She is a graduate of the VISN 9 Midsouth Healthcare Network Leadership Institute.

Over the past thirteen years, Dr. Kane focused her career on compounding pharmacy. While working in community, institutional, and industry settings she developed extensive expertise on the evolving compounding regulation standards. Prior to beginning pharmacy school, Dr. Kane was laboratory manager for an independent community compounding pharmacy. Dr. Kane graduated from Chicago State University-College of Pharmacy with a PharmD degree in 2014. During her time there she focused her studies on improving the focus on compounding within the curriculum. She led the creation of compounding training videos and establishing CSU-COP as a competitor in the regional and national SPCC- Student Pharmacist Compounding Competition. After graduation, Dr. Kane expanded her knowledge by working on Phase 1 and Phase 2 clinical trials with a local drug manufacturer. Currently at University of Chicago, she is working on designing and constructing cleanroom spaces that meet the new cGMP and USP standards.

Carroll is the Vice President of Pharmacy for Option Care Health, the nation’s largest independent provider for home infusion therapy. He has national responsibility for the companies 94 clean rooms as well as all sterile compounding related practices. Carroll has over 20 years in pharmacy leadership in both the home infusion and health system fields. He specializes in clean room and facility design as well as compliance with compounding and regulatory standards. Mike is a graduate of the University of Rhode Island where he received a Bachelor of Science degree. He sits on the Vermont Board of Pharmacy where he served as Chair for 2022-23.

Dr. Filibeck serves as Pentec Health’s Vice President, Pharmacy Innovation providing oversight of the design, buildout and opening of Pentec’s second compounding pharmacy. He received his Bachelor of Science in Pharmacy and Doctorate of Pharmacy degrees from the University of Michigan and his Master of Business Administration degree from Baldwin-Wallace College, Berea, Ohio. During his 40 years in the home and alternate site infusion industry, he has held a number of different roles, ranging from branch pharmacy manager to regional infusion manager for a large, national infusion company. He has been responsible for running the day-to-day operations (including reimbursement) of a hospital-based infusion program and has overseen clinical services in a large, multi-site region. Responsibilities have also included sales support, clinical protocol development, site evaluation and accreditation preparation. Dr. Filibeck has been very active in professional organizations including the American Society of Health-System Pharmacists and the National Home Infusion Association. He is also a member of AMCP. Dr. Filibeck served on the USP Sterile Compounding Expert Panel from 2000 to 2010 during which time USP <797> was released (2004) and updated (2008). Filibeck has earned numerous recognitions, including ASHP Fellow and Distinguished Service Award and NHIA’s Volunteer of the Year Award and NHIA Fellow

Zoe Glaras, PharmD, BCSCP, currently serves as the Pharmacy Manager of Sterile Compounding Quality & Compliance at Yale New Haven Health. In this role she leads the development and maintenance of system-wide policies and standard operating procedures related to sterile compounding and the safe handling of hazardous drugs. Zoe provides critical regulatory support to the pharmacy department across the healthcare system during state, federal, and accreditation inspections. She also oversees the Sterile Compounding Quality Assurance Team, which administers personnel competency assessments to >600 pharmacy personnel across twenty sterile compounding cleanrooms.

Zoe brings nearly two decades of expertise in the sterile compounding industry, with a strong focus on interpreting and applying state and federal regulatory standards. Her passion for sterile compounding began during her time in home infusion and strengthened when she joined the Connecticut Department of Consumer Protection: Drug Control Division. There, she served as a Drug Control Agent, conducting inspections and investigations of pharmacies, hospitals, and manufacturers engaged in sterile and non-sterile compounding activities. Zoe is a member of the National Home Infusion Association (NHIA) and the Connecticut Pharmacist Association (CPA) where she frequently presents on topics related to sterile compounding. Outside of her professional pursuits, Zoe volunteers with BARC-CT, an animal rescue and advocacy organization. She finds joy in fostering dogs and helping them find their “fur-ever” home.

Kenneth “Chip” Lazenby currently serves as the Operations Manager of Decentralized Pharmacy Services at MedStar Georgetown University Hospital in Washington, DC. In this role, he helps oversee state-of-the-art robotic sterile compounding operations for chemotherapy and other hazardous drugs. Previously, he worked at The Queen’s Medical Center in Honolulu, Hawaii, where he oversaw sterile compounding and chemotherapy operations for the state’s largest hospital and only Level 1 Trauma Center. He was also involved in multiple sterile compounding facility redesign projects. Lazenby earned his PharmD from West Virginia University.

Helen McKnight is the Director of Accreditation and Medication Safety for Cardinal Health. In this role, she ensures health system pharmacies are ready for an accreditation organization visit.  When not onsite, she is responsible for oversight, leadership, and communication of accreditation standards and provision of continuing education needs. Her 30-year healthcare career includes practicing pharmacy in Florida, New York, and Alabama. Helen McKnight was the first Alabama pharmacist to pass the BPS Compounded Sterile Preparations exam. She is a member of the American Society of Health System Pharmacists and the Alabama Society of Health System Pharmacists. In addition, she is a lecturer for the University of Wyoming School of Pharmacy, MS-Health Services Administration/Health Institution Leadership program. Helen McKnight holds a Doctor of Pharmacy from the University of Florida and completed her pharmacy practice residency at the University of Maryland Medical System. She earned an MBA from New England College in New Hampshire.

David Melton is an Adjunct Professor at the University of Michigan College of Pharmacy. He also works as a pharmacist specialist on the Compounding Compliance Team serving as a facilities management lead for over 20 sterile and non-sterile locations. He received his Doctorate of Pharmacy and Bachelors in Pharmaceutical Sciences from the University of Toledo.

Denise Rodriguez has over two decades of leadership experience with dedication to the specialized field of compounding. In her current role as the Assistant Director of Pharmacy at The Methodist Hospital and Methodist Children’s Hospital in San Antonio, Texas, Denise is entrusted with oversight of regulatory and accreditation compliance for controlled substances, the safe handling of hazardous medications, nonsterile compounding, and sterile compounding. Denise previously served as Assistant Director for Compounding Quality and Compliance at The Johns Hopkins Hospital (JHH) in Baltimore, Maryland, leading the design, implementation, and oversight of a comprehensive quality assurance program to ensure the safe and effective compounding of medications at nine compounding facilities while upholding regulatory and accreditation requirements. During her tenure at JHH, Denise accomplished the effective integration of robotic enclosures, compounding workflow manager, and compounding compliance software. Denise’s additional achievements comprised of management of cleanroom suite renovation projects and chairing a compounding council to maintain quality control of compounding areas. Denise earned a Bachelor’s degree in pharmacy from Texas Southern University, a Master of Business Administration in Health Care Management at the Johns Hopkins Carey Business School, and is Board Certified as a Sterile Compounding Pharmacist.

With more than 20 years of experience in pharmacy, Dr. Gina Rosito has cultivated a career that bridges clinical practice, hospital leadership, and regulatory compliance. After completing her residency, she began as a clinical pharmacist in pediatric and adult critical care, establishing a strong foundation for future leadership roles. Her career later expanded into operations management, where she developed a specialization in sterile compounding and regulatory oversight. In this capacity, Dr. Rosito collaborated with architects and guided the design and construction of advanced compounding facilities, including segregated satellite pharmacies and state‑of‑the‑art sterile compounding clean rooms. These facilities incorporated hazardous and non‑hazardous suites, reflecting her expertise in USP standards and sterile compounding requirements. Dr. Rosito has played a pivotal role in ensuring compliance with evolving national standards, integrating best practices into facility design, and educating colleagues on the importance of regulatory adherence within a large California health care system. Her ability to combine clinical expertise with regulatory leadership continues to strengthen pharmacy practice, keeping patient safety and compliance at the forefront of sterile compounding operations.